Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial
Richard J. Nowak, Kimiaki Utsugisawa, Michael Benatar, Emma Ciafaloni et autres
Importance: Uncontrolled generalized myasthenia gravis (gMG) can lead to exacerbations that often warrant rescue therapy (RT) use, especially in moderate to severe cases. Inebilizumab, a monoclonal antibody that depletes cluster of differentiation 19+ B cells, demonstrated efficacy and safety in patients with …
us, jp, gb, dk (code pays fourni par la source)